Published research has documented GHK-Cus anti-fibrotic effects in intestinal models, relevant to IBD and gut permeability research
Technical supports: CNW, YSK, VHSC, and JSW
In some cases, healthcare providers may adjust the frequency, for example, some patients might be advised to take the injection twice weekly or once every two weeks, depending on their specific goals and how they respond to treatment
Signs of contaminated product Contaminated or degraded peptides can cause effects unrelated to AOD 9604 itself: Fever or chills following injection, suggesting possible bacterial contamination Severe injection site reactions with significant swelling, heat, or spreading redness Systemic illness symptoms that seem disproportionate to what the peptide should cause Effects that seem completely different from expected AOD 9604 effects If contamination is suspected, stop using that vial immediately
As a case example, body protective compound 157 (BPC-157) is scientifically interesting
